J&J's interest in an Actelion takeover hasn't sparked a deal yet, but it has made CEO Jean-Paul Clozel a billionaire. Thing is, Clozel isn't…

The exec exodus at GlaxoSmithKline is continuing—and so is the rise of women to the company’s top ranks.

AstraZeneca is moving some finance jobs out of the U.K. to Malaysia, Costa Rica and Poland.

Can Roche's Gazyva edge Rituxan even with biosims looming? At least one analyst thinks it may be the only second-gen blood cancer med with a chance to…

Eli Lilly’s Taltz DTC advertising seems to be giving the drug a boost in the battle against Novartis' Cosentyx.

Eli Lilly got a big boost for its diabetes drug franchise on Friday when the FDA approved its SGLT2 diabetes drug Jardiance to reduce the risk of…

In the U.K., more pharma companies are now adopting country-specific social media.

New research found that follow-up studies of cancer drugs that won speedy approvals based on early results found most did not prolong or improve life in…

Pharma